References
- ZajeckaJKornsteinSGBlierPResidual symptoms in major depressive disorder: prevalence, effects, and managementJ Clin Psychiatry201374440741423656849
- RomeraIPérezVCiudadAResidual symptoms and functioning in depression, does the type of residual symptom matter? A post-hoc analysisBMC Psychiatry2013135123398902
- ZimmermanMMartinezJAttiullahNFriedmanMTobaCBoerescuDAHow should residual symptoms be defined in depressed patients who have remitted?Compr Psychiatry2013542919622901599
- McClintockSMHusainMMWisniewskiSRResidual symptoms in depressed outpatients who respond by 50% but do not remit to antidepressant medicationJ Clin Psychopharmacol201131218018621346613
- FavaMBallSNelsonJCClinical relevance of fatigue as a residual symptom in major depressive disorderDepress Anxiety201431325025724115209
- FergusonMDennehyEBMarangellLBMartinezJWisniewskiSRImpact of fatigue on outcome of selective serotonin reuptake inhibitor treatment: secondary analysis of STAR*DCurr Med Res Opin201430102109211824949937
- WooJMJoenHJNohEImportance of remission and residual somatic symptoms in health-related quality of life among outpatients with major depressive disorder: a cross-sectional studyHealth Qual Life Outcomes20141218825519704
- WongpakaranTWongpakaranNPinyopornpanishMBaseline characteristics of depressive disorders in Thai outpatients: findings from the Thai Study of Affective DisordersNeuropsychiatr Dis Treat20141021722324520194
- LotrakulMSukanichPSukyingCThe validity and reliability of the Hamilton Rating scale for depression, Thai versionJ Psychiatric Assoc Thail199641235246
- RabinRde CharroFEQ-5D: a measure of health status from the EuroQol GroupAnn Med200133533734311491192
- HounsomeNOrrellMEdwardsRTEQ-5D as a quality of life measure in people with dementia and their carers: evidence and key issuesValue Health201114239039921402307
- DombrovskiAYCyranowskiJMMulsantBHWhich symptoms predict recurrence of depression in women treated with maintenance interpersonal psychotherapy?Depress Anxiety200825121060106618781665
- ZimmermanMMartinezJHYoungDChelminskiIDalrympleKSeverity classification on the Hamilton depression rating scaleJ Affect Disord2013150238438823759278
- BorgesSChenYFLaughrenTPReview of maintenance trials for major depressive disorder: a 25-year perspective from the US Food and Drug AdministrationJ Clin Psychiatry201475320521424717376
- SeemüllerFMeierSObermeierMThree-year long-term outcome of 458 naturalistically treated inpatients with major depressive episode: severe relapse rates and risk factorsEur Arch Psychiatry Clin Neurosci2014264756757524590257
- TranterRO’DonovanCChandaranaPKennedySPrevalence and outcome of partial remission in depressionJ Psychiatry Neurosci200227424124712174733
- LustbergLReynoldsCFDepression and insomnia: questions of cause and effectSleep Med Rev20004325326212531168
- FalussyLBallaPFrecskaERelapse and insomnia in unipolar major depressionNeuropsychopharmacol Hung201416314114725347243
- SteinertCHofmannMKruseJLeichsenringFRelapse rates after psychotherapy for depression – stable long-term effects? A meta-analysisJ Affect Disord201416810711825043322
- PeselowEDTobiaGKaramiansRPizanoDIsHakWWProphylactic efficacy of fluoxetine, escitalopram, sertraline, paroxetine, and concomitant psychotherapy in major depressive disorder: outcome after long-term follow-upPsychiatry Res2015225368068625496869
- SobockiPEkmanMÅgrenHHealth-related quality of life measured with EQ-5D in patients treated for depression in primary careValue Health200710215316017391424
- SapinCFantinoBNowickiMLKindPUsefulness of EQ-5D in assessing health status in primary care patients with major depressive disorderHealth Qual Life Outcomes200422015128456